On February 25, 2022, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors of Neoleukin Therapeutics, Inc., the Board appointed Rohan Palekar as a Class III director, a member of the Audit Committee of the Board (the "Audit Committee"), and a member of the Compensation Committee of the Board (the "Compensation Committee"), effective as of March 2, 2022. On February 25, 2022, in connection with Mr. Palekar's appointment, the Board accepted the resignation of Lewis T. "Rusty" Williams as a member of the Board and its committees, effective as of the Effective Date.
Also on February 25, 2022, the Board appointed Martin Babler, a member of the Board, to serve as Chairperson of the Compensation Committee, effective
as of the Effective Date.